Martin Carlsson

2.1k total citations
72 papers, 1.5k citations indexed

About

Martin Carlsson is a scholar working on Urology, Rheumatology and Epidemiology. According to data from OpenAlex, Martin Carlsson has authored 72 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Urology, 27 papers in Rheumatology and 16 papers in Epidemiology. Recurrent topics in Martin Carlsson's work include Urinary Bladder and Prostate Research (32 papers), Pelvic floor disorders treatments (25 papers) and Urinary Tract Infections Management (16 papers). Martin Carlsson is often cited by papers focused on Urinary Bladder and Prostate Research (32 papers), Pelvic floor disorders treatments (25 papers) and Urinary Tract Infections Management (16 papers). Martin Carlsson collaborates with scholars based in United States, Sweden and United Kingdom. Martin Carlsson's co-authors include Zhonghong Guan, Tamara Bavendam, Steven A. Kaplan, Claus G. Roehrborn, Eric S. Rovner, Jason Gong, Sender Herschorn, Steven A. Kaplan, Marina Brodsky and Kelly H. Zou and has published in prestigious journals such as JAMA, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Martin Carlsson

70 papers receiving 1.5k citations

Peers

Countries citing papers authored by Martin Carlsson

Since Specialization

Citations

This map shows the geographic impact of Martin Carlsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Carlsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Carlsson more than expected).

Fields of papers citing papers by Martin Carlsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Carlsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Carlsson. The network helps show where Martin Carlsson may publish in the future.

Co-authorship network of co-authors of Martin Carlsson

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Carlsson. A scholar is included among the top collaborators of Martin Carlsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Carlsson. Martin Carlsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival in a Real-World Cohort of Patients With Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis: An Analysis From the Transthyretin Amyloidosis Outcomes Survey (THAOS) 2024 ·Journal of Cardiac Failure ·Pablo García‐Pavía, Arnt V. Kristen, Brian Drachman, Martin Carlsson, Leslie Amass, Franca S. Angeli, Mathew S. Maurer	13
2	Factors associated with disease control failure in acromegaly patients treated with pegvisomant: an ACROSTUDY analysis 2024 ·Endocrine Connections ·Antonella Giampietro, Sabrina Chiloiro, Claudio Urbani, Rosario Pivonello, Martin Carlsson, Francesca Dassie, Nunzia Prencipe, Marta Ragonese, Roy Gomez, (unknown), Salvatore Cannavò, Silvia Grottoli, Pietro Maffei, Annamaria Colao, Fausto Bogazzi, Antonio Bianchi	1
3	What are the chances of improvement or cure from overactive bladder? A pooled responder analysis of efficacy and treatment emergent adverse events following treatment with fesoterodine 2021 ·Neurourology and Urodynamics ·Adrian Wagg, Sender Herschorn, Martin Carlsson, (unknown), Matthias Oelke	6
4	Subjective and objective response to treatment of overactive bladder: A pooled analysis of randomised controlled trials of fesoterodine in patients of >65 years 2020 ·European Urology Open Science ·Adrian Wagg, William Gibson, Martin Carlsson, (unknown)	1
5	Treatment with Growth Hormone in Noonan Syndrome Observed during 25 Years of KIGS: Near Adult Height and Outcome Prediction 2019 ·Hormone Research in Paediatrics ·Michael B. Ranke, Anders Lindberg, Martin Carlsson, Cecilia Camacho‐Hübner, Raoul Rooman	21
6	Symptom relief from OAB: what an"average" patient might expect: data from a pooled analysis of Fesoterodine treated patients 2018 ·Joseph LaBossière, (unknown), Sender Herschorn, Martin Carlsson, Matthias Oelke, Adrian Wagg	2
7	Validation of overactive bladder questionnaire (1-week recall version) in medically complex elderly patients with overactive bladder 2017 ·International Urogynecology Journal ·Alexandra I. Barsdorf, Martin Carlsson, Andrew G. Bushmakin, (unknown), Joseph C. Cappelleri, Andreas M. Pleil	2
8	A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older 2016 ·Age and Ageing ·Adrian Wagg, Daniel Arumí, Sender Herschorn, J.C. Angulo, François Haab, Fady Ntanios, Martin Carlsson, Matthias Oelke	24
9	Optimal Thresholds by Maximizing or Minimizing Various Metrics via ROC-Type Analysis 2013 ·Academic Radiology ·Kelly H. Zou, Ching‐Ray Yu, Kezhen Liu, Martin Carlsson, Javier Cabrera	38
10	Sustained improvement in patient‐reported outcomes during long‐term fesoterodine treatment for overactive bladder symptoms: pooled analysis of two open‐label extension studies 2011 ·British Journal of Urology ·Con Kelleher, Roger R. Dmochowski, Sandra Berriman, Zoë Kopp, Martin Carlsson	11
11	Detecting data fabrication in clinical trials from cluster analysis perspective 2010 ·Pharmaceutical Statistics ·(unknown), Martin Carlsson	10
12	Long-term safety, tolerability and efficacy of fesoterodine treatment in subjects with overactive bladder symptoms 2010 ·International Journal of Clinical Practice ·P.E.V. Van Kerrebroeck, John Heesakkers, Sandra Berriman, Lalitha P. Aiyer, Martin Carlsson, Zhiwei Guan	22
13	Clinically meaningful improvement on the quality of erection questionnaire in men with erectile dysfunction 2009 ·International Journal of Impotence Research ·Kyle Hvidsten, Martin Carlsson, Vera J. Stecher, Tara Symonds, (unknown)	5
14	A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder 2009 ·BMC Medical Research Methodology ·Soyon Lee, Bimal Malhotra, Dana Creanga, Martin Carlsson, Paul Glue	51
15	Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine 2008 ·International Journal of Clinical Practice ·Karin S. Coyne, Victor Elinoff, David A. Gordon, Donna Y. Deng, Marina Brodsky, Dale B. Glasser, Zhanna Jumadilova, Martin Carlsson	17
16	The clinical efficacy of tolterodine extended‐release is maintained for 24 h in patients with overactive bladder 2007 ·British Journal of Urology ·Roger R. Dmochowski, Karl J. Kreder, Scott MacDiarmid, Martin Carlsson, Zhonghong Guan	6
17	Clinically meaningful improvement on the Self-Esteem And Relationship questionnaire in men with erectile dysfunction 2007 ·Quality of Life Research ·Joseph C. Cappelleri, Stanley E. Althof, Michael P. O’Leary, Sidney Glina, Rosie King, Vera J. Stecher, Martin Carlsson, Richard L. Siegel	14
18	Tolterodine and Tamsulosin for Treatment of Men With Lower Urinary Tract Symptoms and Overactive Bladder 2006 ·JAMA ·Steven A. Kaplan, Claus G. Roehrborn, Eric S. Rovner, Martin Carlsson, Tamara Bavendam, Zhonghong Guan	373
19	Tolterodine extended release improves patient-reported outcomes in overactive bladder: results from the IMPACT trial 2006 ·International Journal of Clinical Practice ·Richard Roberts, Tamara Bavendam, Dale B. Glasser, Martin Carlsson, (unknown), Victor Elinoff	33
20	Worst-Case Execution Time Analysis of Disable Interrupt Regions in a Commercial Real-Time Operating System 2002 ·Martin Carlsson, Jakob Engblom, Andreas Ermedahl, (unknown), Björn Lisper	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact